Inflammation on MRI after exposure to ICIs most commonly shows patterns of peripheral inflammatory arthritis and a unique overlap between polymyalgia rheumatica and inflammatory arthritis.

Long-term follow-up data show that the preventive effects of short-term treatment with abatacept disappear after 4-5 years.